Myriad Genetics Inc (MYGN)

Jul 27, 2026

Myriad Genetics rebuilt its AI platform after costs ballooned. Now, it can process documents in seconds. - Business Insider

Jul 27, 2026

Jul 27, 2026

Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 27, 2026

Myriad Genetics Inc (MYGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

TradingKey - TradingKey

Jul 27, 2026

Jul 26, 2026

MYGN|Myriad Genetics Inc|Price:5.610|Chg%:-0.090 - TradingKey

Jul 26, 2026

Jul 25, 2026

Myriad Genetics Inc (MYGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026

Jul 24, 2026

Myriad Genetics, Inc. (MYGN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 24, 2026

Jul 24, 2026

Myriad Genetics, Inc. (MYGN) stock price, news, quote and history - Yahoo Finance UK

Jul 24, 2026

Jul 24, 2026

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $6.14, Implies 8% Upside - TradingView

Jul 24, 2026

Jul 24, 2026

Myriad Genetics Inc (MYGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 23, 2026

3 Reasons MYGN is Risky and 1 Stock to Buy Instead - Yahoo Finance

Jul 23, 2026

Jul 23, 2026

Myriad Genetics stock trades sideways as investors digest recent revenue growth and precision oncolo - Ad-hoc-news.de

Jul 23, 2026

Jul 23, 2026

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026 - The Manila Times

Jul 23, 2026

Jul 23, 2026

Myriad Genetics to Hold Second Quarter 2026 Earnings Conference Call on July 30 - Quiver Quantitative

Jul 23, 2026

Jul 21, 2026

AWHL vs. MYGN: Which women's health diagnostics stock is better now? - MSN

Jul 21, 2026

Jul 21, 2026

Myriad Genetics Launches New Four-in-One Prenatal Genetic Screen - Clinical Lab Products

Jul 21, 2026

Jul 21, 2026

Myriad Genetics launches prenatal genetic screening test By Investing.com - Investing.com Nigeria

Jul 21, 2026

Jul 21, 2026

Myriad Genetics launches prenatal genetic screening test - Investing.com

Jul 21, 2026

Jul 21, 2026

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen - The Manila Times

Jul 21, 2026

Jul 21, 2026

Myriad's one-draw test runs four prenatal screens at 8 weeks - Stock Titan

Jul 21, 2026

Jul 20, 2026

Burning Rock and Myriad Announce Global Strategic Technology Licensing Partnership to Expand HRD Testing Worldwide - EIN News

Jul 20, 2026

Jul 17, 2026

ETFs Investing in Myriad Genetics, Inc. Stocks - TradingView

Jul 17, 2026

Jul 17, 2026

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now? - The Globe and Mail

Jul 17, 2026

Jul 17, 2026

MYGN Stock Price, Quote & Chart - ChartMill

Jul 17, 2026

Jul 15, 2026

Myriad Genetics reports FirstGene prenatal screen achieves over 98 percent sensitivity and 99 percent specificity - Traders Union

Jul 15, 2026

Jul 15, 2026

Is This the Right Time to Hold MYGN Stock in Your Portfolio? - Yahoo Finance

Jul 15, 2026

Jul 15, 2026

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh - qz.com

Jul 15, 2026

Jul 13, 2026

BofA Securities Maintains Myriad Genetics(MYGN.US) With Sell Rating, Announces Target Price $4 - Moomoo

Jul 13, 2026

Jul 11, 2026

Myriad Genetics (MYGN) Q4 2024 earnings summary - Quartr

Jul 11, 2026

Jul 10, 2026

Myriad Genetics (MYGN) Proxy filing Summary - Quartr

Jul 10, 2026

Jul 10, 2026

AI upgrade boosts Prolaris Test predictive power at Myriad Genetics - Traders Union

Jul 10, 2026

Jul 08, 2026

(MYGN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Jul 08, 2026

Jul 06, 2026

Myriad Genetics (MYGN) Surges 3.5%: Approaching Resistance at $6.51ADD Alert - dars.gov.et

Jul 06, 2026

Jul 05, 2026

Myriad Genetics Q1 2026 Earnings: EPS Miss Clouds Diagnostic Growth OutlookGross Profit Margin - dars.gov.et

Jul 05, 2026

Jul 02, 2026

Meta-analysis confirms Myriad's Prolaris test e... - Pluang

Jul 02, 2026

Jul 02, 2026

New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad's Prolaris Biopsy Test in Localized Prostate Cancer - 富途牛牛

Jul 02, 2026

Jul 02, 2026

New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer - Yahoo Finance

Jul 02, 2026

Jul 01, 2026

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS - BioSpace

Jul 01, 2026

Jun 30, 2026

Sera Prognostics adds former Myriad Genetics CEO to board By Investing.com - Investing.com South Africa

Jun 30, 2026

Jun 30, 2026

MYGNMyriad Genetics Inc Latest SEC Filings - Finviz

Jun 30, 2026

Jun 30, 2026

Sera Prognostics adds former Myriad Genetics CEO to board - Investing.com

Jun 30, 2026

Jun 30, 2026

Sera Prognostics adds former Myriad CEO Mark Capone to board - Stock Titan

Jun 30, 2026

Jun 30, 2026

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1 - Yahoo Finance

Jun 30, 2026

Jun 29, 2026

Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock? - Yahoo Finance

Jun 29, 2026

Jun 27, 2026

(MYGN) Risk Channels and Responsive Allocation - Stock Traders Daily

Jun 27, 2026

Jun 27, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jun 27, 2026

Jun 27, 2026

Price to sales forward of Myriad Genetics, Inc. – NASDAQ:MYGN - TradingView

Jun 27, 2026

Jun 27, 2026

Price to book forward of Myriad Genetics, Inc. – NASDAQ:MYGN - TradingView

Jun 27, 2026

Jun 27, 2026

Myriad Genetics, Inc. Actuals & Estimates (NASDAQ:MYGN) - TradingView

Jun 27, 2026